Chelcie Heaney, Ph.D.

Dr. Chelcie Heaney has strong behavioral and molecular neuroscience expertise, including preclinical animal models and mechanisms affecting molecular translation. Her previous research included elucidating the role of inhibitory signaling in learning and memory processes, identifying the key molecular mechanisms associated with the efficacy of rapid antidepressants, utilizing bioinformatics to identify FDA-approved medicines predicted to treat major depression in autism, and examining how major depressive disorder and alcohol use disorders co-occur, with an emphasis on adolescent vulnerability. Dr. Heaney’s work has been supported by various funding sources, including a Graduate Student Scholarship from the American Psychological Foundation and Council of Graduate Departments of Psychology, a National Institutes of Health (NIH) T32 Training Grant from Wake Forest University School of Medicine’s Department of Neuroscience, and a Postdoctoral Fellowship from the Fragile X Research Foundation. At EGC, Dr. Heaney enjoys collaborating with scientists with diverse training backgrounds, and helping clients obtain funding to develop their groundbreaking technologies. In her free time, Dr. Heaney enjoys cooking and baking, solving cryptic crosswords, and exploring the culinary offerings of the cities around her.

 

  • Biotechnology
  • Defense
  • Diagnostics/Assays
  • Medical Devices
  • Pharmaceutical Sciences
  • Instructor, Department of Physiology and Pharmacology, Wake Forest School of Medicine
  • Postdoctoral Fellow, Department of Physiology and Pharmacology, Wake Forest School of Medicine
  • Postdoctoral Fellow, Center for Learning and Memory, University of Texas at Austin
  • B.A. in Psychology with a minor in Biology from Boston University
  • M.A. in Experimental Psychology-Behavioral Neuroscience from University of Nevada, Las Vegas
  • Ph.D. in Experimental Psychology-Behavioral Neuroscience from University of Nevada, Las Vegas